Literature DB >> 16624262

The RyR2 central domain peptide DPc10 lowers the threshold for spontaneous Ca2+ release in permeabilized cardiomyocytes.

Zhaokang Yang1, Noriaki Ikemoto, Graham D Lamb, Derek S Steele.   

Abstract

OBJECTIVE: In vitro experiments have shown that the ryanodine receptor-2 (RyR2) central domain peptide DPc10 (Gly(2460)-Pro(2495)) mimics channel dysfunction associated with catecholaminergic polymorphic ventricular tachycardia (CPVT) by acting competitively to reduce stabilizing interactions between the N-terminal and central domains. In the present study, DPc10 was used as a tool to establish an adult cell model of the disease and to analyse the underlying mechanisms.
METHODS: Rat ventricular myocytes were permeabilized with saponin and perfused with solutions approximating the intracellular milieu containing fluo-3. Sarcoplasmic reticulum (SR) Ca(2+) release was detected using confocal microscopy. DPc10 (10 or 50 microM) was compared with 0.2 mM caffeine, which is known to activate RyR2 and to facilitate Ca(2+)-induced Ca(2+) release (CICR).
RESULTS: Introduction of DPc10 induced a transient increase in spark frequency and a sustained rise in resting [Ca(2+)]. Under conditions causing initial Ca(2+) overload of the SR, DPc10 reduced the frequency and amplitude of spontaneous, propagated Ca(2+) release (SPCR). Following equilibration with 10microM DPc10, the cytosolic [Ca(2+)] threshold for SPCR was markedly reduced and the proportion of spontaneously active cells increased. Caffeine induced a similar, transient increase in spark frequency and a reduction in the [Ca(2+)] threshold for SPCR. However, unlike DPc10, caffeine increased SPCR frequency and had no sustained effect on resting [Ca(2+)]. These results suggest that the net effect of DPc10 (and CPVT mutations) on RyR2 function in situ is not only to increase the sensitivity to CICR as caffeine does, but also to potentiate Ca(2+) leakage from the SR. As SPCR can trigger delayed after-depolarisations, the decrease in [Ca(2+)] threshold may contribute to arrhythmias in CPVT patients during exercise or stress.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16624262     DOI: 10.1016/j.cardiores.2006.03.001

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  9 in total

Review 1.  The molecular basis of catecholaminergic polymorphic ventricular tachycardia: what are the different hypotheses regarding mechanisms?

Authors:  Xander H T Wehrens
Journal:  Heart Rhythm       Date:  2006-12-15       Impact factor: 6.343

Review 2.  Luminal Ca(2+) activation of cardiac ryanodine receptors by luminal and cytoplasmic domains.

Authors:  Derek R Laver
Journal:  Eur Biophys J       Date:  2009-03-03       Impact factor: 1.733

Review 3.  Ca2+ Release Channels Join the 'Resolution Revolution'.

Authors:  Ran Zalk; Andrew R Marks
Journal:  Trends Biochem Sci       Date:  2017-05-09       Impact factor: 13.807

4.  Cardiac arrhythmia mechanisms in rats with heart failure induced by pulmonary hypertension.

Authors:  David Benoist; Rachel Stones; Mark J Drinkhill; Alan P Benson; Zhaokang Yang; Cecile Cassan; Stephen H Gilbert; David A Saint; Olivier Cazorla; Derek S Steele; Olivier Bernus; Ed White
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

5.  Aberrant interaction of calmodulin with the ryanodine receptor develops hypertrophy in the neonatal cardiomyocyte.

Authors:  Jaya P Gangopadhyay; Noriaki Ikemoto
Journal:  Biochem J       Date:  2011-09-01       Impact factor: 3.857

Review 6.  Posttranslational modifications of cardiac ryanodine receptors: Ca(2+) signaling and EC-coupling.

Authors:  Ernst Niggli; Nina D Ullrich; Daniel Gutierrez; Sergii Kyrychenko; Eva Poláková; Natalia Shirokova
Journal:  Biochim Biophys Acta       Date:  2012-08-31

7.  Modeling a ryanodine receptor N-terminal domain connecting the central vestibule and the corner clamp region.

Authors:  Li Zhu; Xiaowei Zhong; S R Wayne Chen; Nilesh Banavali; Zheng Liu
Journal:  J Biol Chem       Date:  2012-11-30       Impact factor: 5.157

8.  A domain peptide of the cardiac ryanodine receptor regulates channel sensitivity to luminal Ca2+ via cytoplasmic Ca2+ sites.

Authors:  Derek R Laver; Bonny N Honen; Graham D Lamb; Noriaki Ikemoto
Journal:  Eur Biophys J       Date:  2007-11-24       Impact factor: 1.733

9.  Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor.

Authors:  Shigeki Kobayashi; Masafumi Yano; Takeshi Suetomi; Makoto Ono; Hiroki Tateishi; Mamoru Mochizuki; Xiaojuan Xu; Hitoshi Uchinoumi; Shinichi Okuda; Takeshi Yamamoto; Noritaka Koseki; Hiroyuki Kyushiki; Noriaki Ikemoto; Masunori Matsuzaki
Journal:  J Am Coll Cardiol       Date:  2009-05-26       Impact factor: 24.094

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.